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Abstract
Aims—A common variant, rs9939609, in the FTO (fat mass and obesity) gene is associated with
adiposity in Europeans, explaining its relationship with diabetes. However, data are inconsistent in
South Asians. Our aim was to investigate the association of the FTO rs9939609 variant with
obesity, obesity-related traits and Type 2 diabetes in South Asian individuals, and to use meta-
analyses to attempt to clarify to what extent BMI influences the association of FTO variants with
diabetes in South Asians.
Methods—We analysed rs9939609 in two studies of Pakistani individuals: 1666 adults aged ≥
40 years from the Karachi population-based Control of Blood Pressure and Risk Attenuation
(COBRA) study and 2745 individuals of Punjabi ancestry who were part of a Type 2 diabetes
case–control study (UK Asian Diabetes Study/Diabetes Genetics in Pakistan; UKADS/DGP). The
main outcomes were BMI, waist circumference and diabetes. Regression analyses were performed
to determine associations between FTO alleles and outcomes. Summary estimates were combined
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in a meta-analysis of 8091 South Asian individuals (3919 patients with Type 2 diabetes and 4172
control subjects), including those from two previous studies.
Results—In the 4411 Pakistani individuals from this study, the age-, sex- and diabetes-adjusted
association of FTO variant rs9939609 with BMI was 0.45 (95% CI 0.24–0.67) kg/m2 per A-allele
(P = 3.0× 10−5) and with waist circumference was 0.88 (95% CI 0.36–1.41) cm per A-allele (P =
0.001). The A-allele (30% frequency) was also significantly associated with Type 2 diabetes [per
A-allele odds ratio (95% CI) 1.18 (1.07–1.30); P = 0.0009]. A meta-analysis of four South Asian
studies with 8091 subjects showed that the FTO A-allele predisposes to Type 2 diabetes [1.22
(95% CI 1.14–1.31); P = 1.07× 10−8] even after adjusting for BMI [1.18 (95% CI 1.10–1.27); P =
1.02× 10−5] or waist circumference [1.18 (95% CI 1.10–1.27); P = 3.97× 10−5].
Conclusions—The strong association between FTO genotype and BMI and waist circumference
in South Asians is similar to that observed in Europeans. In contrast, the strong association of FTO
genotype with diabetes is only partly accounted for by BMI.
Introduction
Cardiometabolic diseases associated with overweight and obesity have become a global
public health problem [1]. The South Asian population has been shown to have one of the
highest risks for these conditions [2,3]. Approximately one in four persons aged 15 years or
above is already overweight or obese in Pakistan and 20% of those aged 40 years or above
suffer from diabetes [4].
Large-scale studies in Europeans have highlighted the significance of common variants in
the FTO (fat mass- and obesity-associated) gene for susceptibility to adiposity. The
adiposity-associated FTO variants are also associated with Type 2 diabetes, although recent
studies of different ethnic groups have demonstrated apparent differences in the way that
FTO contributes to disease risk. In populations of European origin, the strong association
first observed between FTO single nucleotide polymorphisms and Type 2 diabetes was
completely removed by adjusting for BMI [5]. Several studies of Europeans support these
original findings [6–8], although others report BMI-independent associations between FTO
variants and diabetes [9,10]. Studies in East Asian individuals show that, whilst the FTO risk
allele is rarer compared with Europeans, it has a similar effect on body mass index [11–15].
In contrast, there are few studies of FTO in South Asians. One study consisted of a relatively
small sample size—532 patients with Type 2 diabetes and 386 control subjects from the
Sikh community in Northern India—and the other study showed a very weak association
between FTO and BMI [16,17]. Both studies suggested the FTO association with Type 2
diabetes remained after adjusting for BMI.
To provide more definitive evidence for the role of FTO variation in BMI and Type 2
diabetes in South Asians, we used data from 1666 individuals recruited to the Karachi
population-based Control of Blood Pressure and Risk Attenuation (COBRA) study and 2745
individuals of Punjabi ancestry ascertained as part of a Type 2 diabetes case–control study,
the UK Asian Diabetes Study/Diabetes Genetics in Pakistan (UKADS/DGP). We assessed
the relationship of the FTO rs9939609 variant with measures of adiposity (BMI and waist
circumference) and with fasting glucose and Type 2 diabetes. We meta-analysed our results
with those from two previously published papers describing the effect of FTO variants in
South Asians.
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Research design and methods
COBRA study
Study design—A population-based sample representative of adults in Karachi was
recruited in a cluster randomized trial of strategies to control hypertension. Ethical approval
was obtained from the Ethics Review Committee at the Aga Khan University, Pakistan. The
sampling details have been described previously [2]. Briefly, a multistage cluster random
sampling design was used to randomly select 12 geographical clusters in Karachi, the largest
metropolitan city in Pakistan. A census was carried out and a listing of all individuals from
all households in the selected areas was made. All subjects aged 40 years or above and able
to consent were invited to participate in the study by trained community health workers. All
subjects were evaluated after informed consent was obtained. A range of anthropometric and
biochemical data were collected for all subjects. Information on use of anti-diabetes
medication was recorded. Diabetes was defined as fasting plasma glucose > 7.0 mmol/l (126
mg/dl) or taking anti-diabetes medication [18]
UKADS/DGP study
Study design—Participants in the study were from two genetically homogeneous Punjabi
populations, one resident in the UK and one indigenous to the Mirpur region of Azad
Kashmir, Pakistan. Informed consent was obtained from all study participants and the study
was approved by the Birmingham East, North and Solihull Research Ethics Committee and
the Baqai Institute of Diabetology and Endocrinology Institutional Review Board. All
subjects were of Punjabi ancestry, confirmed over three generations, and originated
predominantly from the Mirpur District, Pakistan. A range of anthropometric and
biochemical data were collected for all subjects.
UKADS subjects—UK-resident subjects with Type 2 diabetes (n = 892) were recruited to
the UKADS [19] from Birmingham and Coventry. Ethnically matched control subjects (n =
287) were recruited from the same geographical areas through community screening. As
control subjects were recruited from community venues and places of worship, fasting
samples or oral glucose tolerance tests were not feasible. Normal glucose tolerance was
therefore defined as random blood glucose < 7 mmol/l. Genomic DNA was extracted from
venous blood using the Nucleon® protocol (Nucleon Biosciences, Coatbridge, UK).
DGP subjects—Indigenous Pakistani subjects were recruited in collaboration with the
Baqai Institute of Diabetology and Endocrinology, Karachi, Pakistan, as part of the DGP
study. Subjects with Type 2 diabetes (n = 717) were recruited either from hospitals within
Mirpur District or from specifically organized Diabetes Awareness camps. Control subjects
(n = 912) were recruited from community screening camps set up throughout Mirpur
District. Normal glucose tolerance was defined as fasting whole blood glucose ≤ 5.6 mmol/l.
Genomic DNA was extracted from saliva using the Oragene® DNA sample collection kit
and extraction protocol (DNA Genotek Inc., XXXXX, ON, Canada).
Genotyping
All subjects (UKADS/DGP, n = 2808; COBRA, n = 1718) were genotyped for the FTO
rs9939609 single nucleotide polymorphism using either TaqMan genotyping assays
(Applied Biosystems, Warrington, UK) or the KASPar® method (KBiosciences, Hoddesdon,
UK). Genotype success rates were 98% (UKADS/DGP) and 97% (COBRA), resulting in
4411 subjects being successfully genotyped (UKADS/DGP, n = 2745; COBRA, n = 1666).
Blind duplicates were genotyped (UKADS/DGP, 10.4%; COBRA, 7.6%) resulting in error
rates of 0% (0/286) and 2.1% (3/141), respectively.
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Statistical analyses
Deviation from Hardy–Weinberg equilibrium in the groups without diabetes was tested
using a χ2 goodness-of-fit test (UKADS: χ2 = 0.06, d.f. = 1, P = 0.80; DGP: χ2 = 0.18, d.f. =
1, P = 0.67; COBRA: χ2 = 0.07, d.f. = 1, P = 0.79). Association between the single
nucleotide polymorphism and categorical variables such as Type 2 diabetes and obesity
category was tested using logistic regression. The association between rs9939609 and Type
2 diabetes was tested before and after adjusting for BMI and waist circumference. Obesity
categories were defined in line with recently presented guidelines for Indian Asian
populations [20]. A BMI of < 23 kg/m2 was classified as normal weight or underweight, 23
to <25 kg/m2 as overweight and ≥ 25 kg/m2 as obese. Linear regression was used to test
association between rs9939609 and continuous variables. All regression analyses were
adjusted for age, sex and diabetes as appropriate. All analyses in the COBRA study
accounted for clustering at the census level. For the UKADS/DGP study, analyses were
adjusted for country of residence. Heterogeneity of effect sizes between the UKADS and
DGP cohorts was assessed using Cochran’s Q statistics; no significant heterogeneity was
observed for either the BMI (P = 0.747), waist circumference (P = 0.909), overweight/
obesity (P = 0.546) or Type 2 diabetes (P = 0.463) analyses. Genotype distributions were
compared between subjects without diabetes from the studied groups using a χ2-test of
independence (see also Supporting Information, Table S1). Summary statistics from the
COBRA and UKADS/DGP studies were combined using an inverse variance weighted
meta-analysis, implemented in the Stata module Metan. Within the COBRA study, a
sensitivity analysis was performed on those belonging to the single largest ethnic subgroup
(Muhajirs); the per FTO A-allele increase in BMI was calculated for both the Muhajir group
and the whole COBRA group. Heterogeneity of these effect sizes was tested using
Cochran’s Q statistics (see also Supporting Information, Table S2). All statistical analyses
were performed using Stata/IC version 10 (2007) (StataCorp, College Station, TX, USA) or
SAS 9.1.3 (SAS Institute, Cary, NC, USA).
The clinical details of individuals from the two studies are shown in Table 1. Allele
frequencies of rs9939609 were similar to those seen in previously studied Indian Asian
populations [16,17] (see also Supporting Information, Table S1).
Meta-analysis
To assess more comprehensively the role of FTO variation in South Asians, we performed a
meta-analysis of our data with those from two previous publications [16,17]. These
publications represented those identified by a PubMed search of the term ’Asian and
FTO‘ that included FTO genotyping in patients with Type 2 diabetes and control subjects in
individuals from the Indian subcontinent (South Asians). Results of the South Asian meta-
analysis were compared with a similar meta-analysis of previously published studies of
European populations [5–8,10,21], identified by a PubMed search of the term ’FTO and
diabetes‘. Publications were selected for inclusion if they investigated European populations
and reported per FTO risk-allele odds ratios for Type 2 diabetes before and after adjustment
for BMI. Two of the selected studies investigated single nucleotide polymorphisms other
than rs9939609: rs1121980 and rs8050136. These studies were included as both single
nucleotide polymorphisms were good proxies for rs9939609 [r2≥ 0.85 in the CEPH (CEU)
HapMap samples] (Fig. 1). We performed an inverse variance weighted meta-analysis of the
per-allele effect of rs9939609 (or its proxies) on Type 2 diabetes, before and after correcting
for BMI, using the Metan command in Stata/IC (version 10).
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Results
Association of FTO rs9939609 with BMI and obesity in Pakistani individuals
We observed a significant increase in BMI with increasing numbers of A-alleles in both the
COBRA study [0.52 kg/m2 (95% CI 0.15–0.89); P = 0.006] and the UKADS/DGP study
[0.42 kg/m2 (95% CI 0.16–0.68); P = 0.002] and when combined in a meta-analysis of the
two studies [0.45 kg/m2 (95% CI 0.24–0.67); P = 3.0× 10−5]. A similar pattern was
observed for waist circumference, with a per-allele effect of 1.20 cm (95% CI 0.33–2.07; P
= 0.007) in the COBRA study, 0.70 cm (95% CI 0.04–1.37; P = 0.038) in the UKADS/DGP
study and 0.88 cm (95% CI 0.36–1.41; P = 0.001) in a meta-analysis of the two studies.
When BMI was split into a dichotomous trait of overweight/obesity vs. normal weight
(defined as BMI ≥ 23 vs. < 23 kg/m2) we again saw a similar effect, with a per-allele effect
of odds ratio of 1.21 (95% CI 1.03–1.41; P = 0.02) in the COBRA study, 1.13 (95% CI
0.97–1.30; P = 0.11) in the UKADS/DGP study and 1.17 (95% CI 1.05–1.30; P = 0.005) in
the meta-analysis (Table 2).
Association of FTO rs9939609 with Type 2 diabetes in Pakistani individuals
We observed an association of FTO genotype with Type 2 diabetes in both studies, each
copy of the A-allele increasing the risk of diabetes with an odds ratio of 1.21 (95% CI 1.02–
1.45; P = 0.03, age- and sex-adjusted) in the COBRA study, 1.17 (95% CI 1.03–1.31; P =
0.01, age-, sex- and cohort-adjusted) in the UKADS/DGP study and 1.18 (95% CI 1.07–
1.30; P = 0.0009) in a meta-analysis of the two studies. These associations remained very
similar when adjusting for BMI, with odds ratios of 1.17 (95% CI 0.97–1.41; P = 0.09) in
the COBRA study, 1.14 (95% CI 1.01–1.29; P = 0.03) in the UKADS/DGP study and 1.15
(95% CI 1.04–1.27; P = 0.008) in a meta-analysis of the two studies; or waist circumference,
with odds ratios of 1.15 (95% CI 0.94–1.41; P = 0.17) in the COBRA study, 1.15 (95% CI
1.01–1.30; P = 0.03) in the UKADS/DGP study and 1.15 (95% CI 1.03–1.28; P = 0.01) in a
meta-analysis of the two studies. We also observed an association between FTO genotype
and fasting glucose across all individuals in the COBRA cohort, and this also remained
similar even after adjusting for BMI or waist circumference (Table 3).
Meta-analysis of association of FTO variant with Type 2 diabetes in South Asian
individuals
A meta-analysis of our two studies and two other South Asian studies showed that the
association between FTO genotype and Type 2 diabetes is only partly accounted for by
BMI, with a combined odds ratio for Type 2 diabetes of 1.22 (95% CI 1.14–1.31; P = 1.07×
10−8) before adjusting for BMI and 1.18 (95% CI 1.10–1.27; P = 1.02× 10−5) after adjusting
for BMI (Fig. 1). The association between rs9939609 and diabetes also remained significant
after adjustment for waist circumference in the South Asians [see also Supporting
Information, Fig. S1; odds ratio 1.18 (95% CI 1.10–1.27); P = 3.97× 10−5). This meta-
analysis includes data from both a population-based cohort and case–control studies, but,
despite differences in study design, effect sizes for all studies of people of South Asian
origin were very similar, both before (P for heterogeneity = 0.83) and after (P for
heterogeneity = 0.86) adjustment for BMI. In a meta-analysis of six published studies
investigating European populations [5–8,10,21], we found that the association between FTO
and Type 2 diabetes was greatly reduced by adjusting for BMI [unadjusted: odds ratio 1.15
(95% CI 1.11–1.18), P = 2.07× 10−20; BMI-adjusted: odds ratio 1.06 (95% CI 1.03–1.10), P
= 4.72× 10−4], although it did retain significance (Fig. 1). The BMI-adjusted effect size,
however, was significantly larger in the South Asians compared with the Europeans
(heterogeneity P = 0.009).
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Discussion
Our study is the first from Pakistan to investigate the association of the FTO variant
rs9939609 with obesity-related traits and diabetes and the first meta-analysis of several
studies from South Asian individuals. We found that the FTO variant is strongly associated
with body mass index and waist circumference in the COBRA and UKADS/DGP studies of
South Asians, in keeping with multiple reports in European individuals. The estimate of the
per-allele effect of each FTO rs9939609 A-allele is 0.45 (95% CI 0.24–0.67) kg/m2, which
is very similar to the estimate of 0.39 kg/m2 in Europeans reported by the Genomewide
Investigation of Anthropometric Measures (GIANT) consortium [22]. The most important
finding from our study is that we have shown a robust association between an FTO variant
and Type 2 diabetes in South Asian individuals, and that this association is only partially
attenuated by accounting for BMI or waist circumference. In contrast, a meta-analysis of the
association between FTO variants and Type 2 diabetes in European individuals showed a
much reduced effect when accounting for BMI.
While the association of FTO with diabetes has been reported previously by two case–
control studies from the Indian subcontinent, this relationship could not be explained by
BMI or waist circumference [16,17]. However, these two studies were either relatively small
in sample size [17] or showed inconclusive effects of the FTO variant on BMI [16]. Genetic
association studies have repeatedly shown that meta-analyses of several studies provide a
more accurate estimate of the real effect—mainly because they increase power. Our meta-
analysis, including a total of 3919 South Asian patients with Type 2 diabetes and 4172
control subjects, provides strong evidence that, in South Asians, BMI and central obesity
can only partly account for the association between the FTO A-allele and diabetes. We have
also shown, through meta-analysis of six studies of Europeans, that adjusting for BMI
partially accounts for the association between FTO and Type 2 diabetes in Europeans as
well as South Asians. However, the effect of BMI adjustment is much stronger in Europeans
compared with South Asians, with most of the Type 2 diabetes association accounted for.
We suggest that BMI may be a poorer surrogate measure of adiposity in South Asians
compared with Europeans. It is also possible that a single cross-sectional measure of BMI
does not adequately reflect the lifelong effects of the FTO polymorphism, and this
contributes to residual association between FTO and diabetes in both ethnic groups. In our
study of South Asians, adjustment for waist circumference does not appear to explain much
more of the association between the FTO variant and diabetes compared with BMI
adjustment. This is surprising as central obesity is a particularly well-established correlate of
diabetes and cardiovascular risk in South Asians [23].
Our study has limitations. We did not use an oral glucose tolerance-based test to characterize
control subjects and it is possible that the control populations contain a small proportion of
subjects with undiagnosed diabetes, but this issue is unlikely to result in false positive
associations and population-based controls have been successfully used in many genetic
studies of Type 2 diabetes. The differences in study designs (cross-sectional and case–
control) add to the complexity of interpreting the pooled results, such as those related to the
clinical expression and diagnosis of disease. However, the consistency of our main results
across several studies means we believe our results are robust and generalizable to the vast
majority of native and migrant populations of the Indian subcontinent. Clearly, these
findings are of importance as approximately half the population has at least one FTO
adiposity-increasing allele. Moreover, the prevalence of overweight and obesity is rapidly
escalating in the youth and adults of Pakistan, further enhancing the risk of diabetes [24].
Our findings suggest that this risk is especially elevated in those with the A-allele at FTO
variant rs9939609.
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In conclusion, we observed a significant association of FTO rs9939609 A-alleles with Type
2 diabetes in South Asians, but this relationship was only partly accounted for by BMI or
waist circumference. Overall, our results indicate that the FTO variant has similar effects on
BMI and waist circumference in Pakistani individuals compared with Europeans. In contrast
to Europeans, where most of the Type 2 diabetes association is explained by BMI
adjustment, the effect of the FTO variant on diabetes in Pakistani individuals appears to be
only partly accounted for by the effects of FTO on BMI and waist circumference. This could
be explained by a poorer correlation between surrogate measures of adiposity and true levels
and distributions of adiposity in South Asians compared with Europeans.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
Meta-analysis plots for the association between the FTO rs9939609 single nucleotide
polymorphism and Type 2 diabetes before (a) and after (b) adjustment for BMI. In the
pooled South Asian populations, rs9939609 was significantly associated with diabetes
before (P = 1.07× 10−8) and after (P = 1.02× 10−5) BMI adjustment. Significant
heterogeneity was detected between the South Asian studies and the European studies after
BMI adjustment (P = 0.009). The single nucleotide polymorphisms included in the meta-
analysis from Renstrom et al. (7) and Thorleiffsson et al. (8) were rs1121980 and
rs8050136, respectively, both of which are good proxies for rs9939609 [D’/r2 values of 1/1
and 0.96/0.85, respectively, estimated using the CEPH (CEU) HapMap samples]. Data from
Sanghera et al [17] (using subjects from the Sikh Diabetes Study) were reanalysed to give
allelic odds ratios before inclusion in the meta-analysis. COBRA, Control of Blood Pressure
and Risk Attenuation; DGP, Diabetes Genetics in Pakistan; UKADS, UK Asian Diabetes
Study.
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Table 1
Demographic and health characteristics of study participants in the two studies
UKADS/DGP study COBRA study
Control subjects
Subjects with Type 2
diabetes Population control subjects
Subjects with Type 2
diabetes
n 1177 1568 1281 385
Age (years) 56.4 (10.7) 55.8 (11.9) 51.1 (10.7) 53.5 (10.7)
Per cent male 50.0 51.6 46.3 40.0
Fasting plasma glucose (mmol/l) 5.4 (0.6)* N/A 5.3 (0.6) 10.6 (4.0)
Systolic blood pressure (mmHg) 132.0 (20.3) 137.9 (21.1) 135.6 (22.8) 143.4 (24.2)
Diastolic blood pressure (mmHg) 83.7 (11.6) 84.5 (11.3) 85.9 (12.8) 88.3 (12.6)
Total cholesterol (mmol/l) 4.8 (1.2) 4.8 (1.1) 4.8 (1.0) 5.0 (1.2)
LDL cholesterol (mmol/l) 2.9 (1.1) 2.7 (1.1) 3.0 (0.8) 3.1 (0.9)
HDL cholesterol (mmol/l) 1.2 (0.3) 1.2 (0.4) 1.1 (0.3) 1.0 (0.3)
Random blood glucose (mmol/l) 5.4 (0.9)† N/A N/A N/A
HbA1c (%) N/A 9.0 (2.7)‡ N/A N/A
Triglycerides (mmol/l) 1.8 (1.0) 2.5 (1.8) 1.7 (0.9) 2.2 (1.3)
BMI (kg/m2) 25.7 (5.2) 27.5 (4.8) 25.2 (5.2) 26.7 (5.6)
Waist circumference (cm) 93.8 (13.0) 99.8 (11.4) 88.1 (12.0) 93.2 (11.7)
Height (m) 1.6 (0.1) 1.6 (0.1) 1.6 (0.1) 1.6 (0.1)
Weight (kg) 68.7 (14.8) 73.9 (13.6) 63.4 (13.8) 66.4 (15.0)
Except where specified, values are means (SD).
*
In the DGP control subjects, fasting plasma glucose is estimated from fasting whole blood glucose measurement, using a conversion factor of
1.15.
†
Random blood glucose recorded for UKADS control subjects only.
‡
HbA1c recorded for UKADS/DGP subjects with diabetes only.
COBRA, Control of Blood Pressure and Risk Attenuation; DGP, Diabetes Genetics in Pakistan; N/A, not available; UKADS, UK Asian Diabetes
Study.
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